OXFORD NANOPORE TECHNOLOGIES PL (ONT.L) Financials

ONT.L Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 75.9 billion 11.8 billion
2023-03-31 75.9 billion 11.8 billion
2022-12-31 82.4 billion 13.0 billion
2022-09-30 82.4 billion 13.0 billion

ONT.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 -6.8 billion 1.1 billion
2023-03-31 -3.3 billion 1.1 billion
2022-12-31 -7.5 billion 1.3 billion
2022-09-30 -3.3 billion 1.3 billion

ONT.L Net Income

No data available :(

ONT.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 37.6 billion - 3.3 billion
2023-03-31 37.6 billion - -
2022-12-31 47.6 billion - 3.4 billion
2022-09-30 47.6 billion - -

ONT.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 82.7 billion
2023-03-31 82.7 billion
2022-12-31 82.4 billion
2022-09-30 82.5 billion

ONT.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 2.3 billion 4.8 billion - -
2023-03-31 700.8 million 2.4 billion - -
2022-12-31 2.4 billion 4.0 billion - -
2022-09-30 706.1 million 2.0 billion - -

ONT.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 8.6 billion 3.6 billion
2023-03-31 4.3 billion 1.8 billion
2022-12-31 7.6 billion 3.0 billion
2022-09-30 3.8 billion 1.5 billion

ONT.L

Price: £0.98

52 week price:
92.75
279.00

Earnings Per Share: -0.15 GBp

P/E Ratio: -10.39

Exchange: LSE

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 958.3 million

Links: